Viewing Study NCT05570305


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-02-11 @ 7:57 AM
Study NCT ID: NCT05570305
Status: COMPLETED
Last Update Posted: 2025-04-30
First Post: 2022-10-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
Sponsor: University Medical Center Groningen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetic Nephropathies View
None Albuminuria View
None Chronic kidney disease View
None Endothelin receptor antagonists View
None Sodium Glucose Co Transporter 2 inhibitors View